Common use of Reports; Payments Clause in Contracts

Reports; Payments. Within [***] ([***]) days after the end of each Calendar Quarter during which there are Net Sales giving rise to a payment obligation under Section 6.2 or uniQure (or 4DMT, as applicable) received Sublicense Consideration or 4D Sublicense Consideration giving rise to a payment obligation under Section 6.3, (a) uniQure (or 4DMT as applicable) shall submit to 4DMT (or uniQure as applicable) a report (i) identifying for each Royalty Bearing Product the Net Sales for such Royalty Bearing Product for each country for such Calendar Quarter, the calculation of royalties (including gross sales and all deductions taken from gross sales and all reductions pursuant to Section 6.2(c)), and the royalties payable to 4DMT (or uniQure as applicable) and (ii) identifying the Sublicense Consideration received by uniQure (or 4DMT as applicable) in such Calendar Quarter and the one or more Sublicense Income Sharing Percentages applicable to such Sublicense Consideration, or 4D Sublicense Income Sharing Percentages applicable to such 4D Sublicense Consideration and (b) uniQure (or 4DMT as applicable) shall pay to 4DMT (or uniQure as applicable) all royalties payable under Section 6.2 and portions of Sublicense Consideration or 4D Sublicense Consideration payable under Section 6.3.

Appears in 2 contracts

Samples: Collaboration and License Agreement (4D Molecular Therapeutics Inc.), Collaboration and License Agreement (uniQure N.V.)

AutoNDA by SimpleDocs

Reports; Payments. Within [***] ([***]) days after the end of each Calendar Quarter during which there are Net Sales or 4DMT Net Sales giving rise to a payment obligation under Section 6.2 6.4 or uniQure or 4DMT (or 4DMT, as applicable) received Sublicense Consideration or 4D Sublicense Consideration giving rise to a payment obligation under Section 6.36.5, (a) uniQure (or 4DMT (as applicable) shall submit to 4DMT (or uniQure (as applicable) a report (i) identifying for each Royalty Bearing Product the Net Sales or 4DMT Net Sales for such Royalty Bearing Product for each country for such Calendar Quarter, the calculation of royalties (including gross sales and all deductions taken from gross sales and all reductions pursuant to Section 6.2(c6.4(c)), and the royalties payable to 4DMT (or uniQure (as applicable) and (ii) identifying the Sublicense Consideration or 4D Sublicense Consideration received by uniQure (or 4DMT (as applicable) in such Calendar Quarter and the one or more Sublicense Income Sharing Percentages applicable to such Sublicense Consideration, or 4D Sublicense Income Sharing Percentages applicable to such 4D Sublicense Consideration Consideration, and (b) uniQure (or 4DMT (as applicable) shall pay to 4DMT (or uniQure (as applicable) all royalties payable under Section 6.2 6.4 and portions of Sublicense Consideration or 4D Sublicense Consideration payable under Section 6.36.5.

Appears in 2 contracts

Samples: Collaboration and License Agreement (4D Molecular Therapeutics Inc.), Collaboration and License Agreement (uniQure N.V.)

AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!